Prevalence, screening and treatment of chronic kidney disease in people with type 2 diabetes in France: The ENTRED surveys (2001 and 2007)

Diabetes and Metabolism

Volumn 38, Issue 6, 2012, Pages 558-566

  Assogba, G F A ^a,b   Couchoud, C ^b   Roudier, C ^a   Pornet, C ^a   Fosse, S ^a   Romon, I ^a   Druet, C ^a   Stengel, B ^c   Fagot Campagna, A ^a  

^a French Institute for Public Health Surveillance   (France)

^b AGENCE DE LA BIOMÉDECINE   (France)

^c CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

Author keywords

Albuminuria; Chronic kidney disease; ENTRED; Epidemiology; Prevalence; Quality of care; Screening; Type 2 diabetes

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; DIABETIC PATIENT; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; QUALITY CONTROL; REIMBURSEMENT;

AGED; ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; FRANCE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RENAL INSUFFICIENCY, CHRONIC;

EID: 84870660180     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2012.08.004     Document Type: Article

References (32)

1. King H., Aubert R.E., Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998, 21:1414-1431.
2. Ricci P., Blotière P.O., Weill A., Simon D., Ricordeau P., Allemand H. Treated diabetes: which trends between 2000 and 2009 in France?. Bull Epidemiol Hebd 2010, 42-43:409-413.
3. Ricci P., Chantry M., Detournay B., Poutignat N., Kusnik-Joinville O., Raimond V., et al. Reimbursed health expenditures of people treated for diabetes by the French National Health Insurance Fund: 2001 and 2007 ENTRED Surveys. Bull Epidemiol Hebd 2009, 42-43:464-469.
4. Biomedecine Agency. Annual report of French ESRD registry. [Accessed February 7, 2012]. http://www.agence-biomedecine.fr/article/142.
5. Ministry of Health. The health of the population in France Paris, Directorate for Research. Studies Assessment and Statistics of Ministry of Health; 2011. Available at [Accessed February, 2012]. http://www.sante.gouv.fr/l-etat-de-sante-de-la-population-en-france-rapport-2011.html.
6. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39:S1-S266.
7. Diagnosis of end-stage renal disease in adults. National Agency for Accreditation and Evaluation of Health Care. Available at [Accessed February, 2012]. http://www.hassante.fr/portail/jcms/c_272222/diagnostic-de-linsuffisance-renale-chronique-chez-ladulte.
8. Bonnet F., Gauthier E., Gin H., Hadjadj S., Halimi J.M., Hannedouche T., et al. Expert consensus on management of diabetic patients with impairment of renal function. Diabetes Metab 2011, 37(Suppl 2):S1-S25.
9. France's health surveillance institute Entred 2007 survey protocol 2007, 56.
10. Marant C., Romon I., Fosse S., Weill A., Simon D., Eschwege E., et al. French medical practice in type 2 diabetes: the need for better control of cardiovascular risk factors. Diabetes Metab 2008, 34:38-45.
11. France's Health Surveillance Institute: ENTRED website. Available at [Accessed February, 2012]. http://www.invs.sante.fr/surveillance/diabete/entred_2007_2010/Protocole_hors_annexe.pdf.
12. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth DN A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation: Modification of Diet in renal Disease Study Group. Ann Intern Med 1999, 30:461-470.
13. Treatment strategies to slow the progression of chronic renal failure in adults. Available at [Accessed February, 2012]. http://www.has-sante.fr/portail/jcms/c_272372/moyens-therapeutiques-pour-ralentir-la-progression-de-linsuffisance-renale-chronique-chez-ladulte.
14. Coresh J., Selvin E., Stevens L.A., Manzi J., Kusek J.W., Eggers P., et al. Prevalence of chronic kidney disease in the United States. JAMA 2007, 298:2038-2047.
15. van der Meer V., Wielders H.P., Grootendorst D.C., de Kanter J.S., Sijpkens Y.W., Assendelft W.J., et al. Chronic kidney disease in patients with diabetes mellitus type 2 or hypertension in general practice. Br J Gen Pract 2010, 60:884-890.
16. Jia W., Gao X., Pang C., Hou X., Bao Y., Liu W., et al. Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS). Nephrol Dial Transplant 2009, 24:3724-3731.
17. Lou Arnal L.M., Campos G.B., Cuberes I.M., Gracia G.O., Turon Alcaine J.M., Bielsa G.S., et al. Prevalence of chronic kidney disease in patients with type 2 diabetes mellitus treated in primary care. Nefrologia 2010, 30:552-556.
18. Lu B., Wen J., Song X.Y., Dong X.H., Yang Y.H., Zhang Z.Y., et al. High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown. Diabetes Res Clin Pract 2007, 75:184-192.
19. Ohta M., Babazono T., Uchigata Y., Iwamoto Y. Comparison of the prevalence of chronic kidney disease in Japanese patients with type 1 and type 2 diabetes. Diabet Med 2010, 27:1017-1023.
20. Middleton R.J., Foley R.N., Hegarty J., Cheung C.M., McElduff P., Gibson J.M., et al. The unrecognized prevalence of chronic kidney disease in diabetes. Nephrol Dial Transplant 2006, 21:88-92.
21. Thomas M.C., Weekes A.J., Broadley O.J., Cooper M.E., Mathew T.H. The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study). Med J Aust 2006, 185:140-144.
22. Dyer A.R., Greenland P., Elliott P., Daviglus M.L., Claeys G., Kesteloot H., et al. Evaluation of measures of urinary albumin excretion in epidemiologic studies. Am J Epidemiol 2004, 160:1122-1131.
23. Warram J.H., Gearin G., Laffel L., Krolewski A.S. Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 1996, 7:930-937.
24. Ginsberg J.M., Chang B.S., Matarese R.A., Garella S. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 1983, 309:1543-1546.
25. Dunn P.J., Jury D.R. Random urine albumin:creatinine ratio measurements as a screening test for diabetic microalbuminuria - a five year follow up. N Z Med J 1990, 103:562-564.
26. Mosca A., Paleari R., Ceriotti F., Lapolla A., Fedele D. Biological variability of albumin excretion rate and albumin-to-creatinine ratio in hypertensive type 2 diabetic patients. Clin Chem Lab Med 2003, 41:1229-1233.
27. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
28. Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000, 321:405-412.
29. UK Prospective Diabetes Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998, 317:703-713.
30. Kshirsagar A.V., Joy M.S., Hogan S.L., Falk R.J., Colindres R.E. Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials. Am J Kidney Dis 2000, 35:695-707.
31. Brenner B.M., Cooper M.E., De Z.D., Keane W.F., Mitch W.E., Parving H.H., et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001, 345:861-869.
32. Hou F.F., Zhang X., Zhang G.H., Xie D., Chen P.Y., Zhang W.R., et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med 2006, 354:131-140.